Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(7):480; doi:10.1093/jnci/97.7.480
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

Awards, Appointments, Announcements

{blacksquare} The American Society of Clinical Oncology (ASCO) has announced the results of its election of officers.

Gabriel N. Hortobagyi, M.D., has been elected president of ASCO for a 1-year term beginning in June 2006. He will take office as president-elect at the ASCO annual meeting this May. Hortobagyi is chairman of the Department of Breast Medical Oncology and professor of medicine at the University of Texas M. D. Anderson Cancer Center in Houston.

ASCO has also elected four new board members. Jamie H. Von Roenn, M.D., of the Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago, and George W. Sledge Jr., M.D., of the Indiana University School of Medicine and the Indiana University Cancer Center, will serve in Undesignated Specialty, Oncology, or Hematology/Oncology seats on the board. Alexander M. M. Eggermont, M.D., Ph.D., of the Erasmus University Medical Center, Daniel Den Hoed Cancer Center, the Netherlands, will serve in a Surgical Oncology seat. Barbara L. McAneny, M.D., of New Mexico Oncology/Hematology Consultants, will serve in a Community Oncology seat.

{blacksquare} Alfred G. Knudson Jr., M.D., Ph.D., has been selected to receive the 28th Annual Bristol-Myers Squibb "Freedom to Discover" Award for Distinguished Achievement in Cancer Research for his "two-hit model" that explains how cancer develops when tumor-suppressor genes are damaged. Knudson is a distinguished scientist and senior adviser to the president at the Fox Chase Cancer Center in Philadelphia. He will receive his award October 19.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?